Back to Search
Start Over
Intravitreal bevacizumab (avastin) combined with vitrectomy for recurrences of proliferative vitreoretinopathy in Von Hippel-Lindau disease.
- Source :
-
Acta ophthalmologica [Acta Ophthalmol] 2012 Mar; Vol. 90 (2), pp. e157-8. Date of Electronic Publication: 2011 Jun 08. - Publication Year :
- 2012
- Subjects :
- Adult
Bevacizumab
Combined Modality Therapy
Female
Humans
Intravitreal Injections
Male
Recurrence
Treatment Outcome
Vascular Endothelial Growth Factor A antagonists & inhibitors
Vitreoretinopathy, Proliferative diagnosis
Vitreoretinopathy, Proliferative etiology
von Hippel-Lindau Disease diagnosis
Angiogenesis Inhibitors therapeutic use
Antibodies, Monoclonal, Humanized therapeutic use
Vitrectomy
Vitreoretinopathy, Proliferative therapy
von Hippel-Lindau Disease complications
Subjects
Details
- Language :
- English
- ISSN :
- 1755-3768
- Volume :
- 90
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Acta ophthalmologica
- Publication Type :
- Report
- Accession number :
- 21649868
- Full Text :
- https://doi.org/10.1111/j.1755-3768.2011.02108.x